Grammarly's "Expert Review": A $100M+ Revenue Play or a Legal Minefield?

The feature launch is a direct monetization play on high-value academic and professional users. Grammarly's rebranding to Superhuman signals a major push into premium AI services, and the "Expert Review" tool is a key part of that strategy. It targets users willing to pay for perceived expert validation, whether from living luminaries like Neil deGrasse Tyson or deceased scholars like Carl Sagan. This positions the tool as a high-margin add-on within the subscription model, aiming to capture spending from students and researchers who see it as a competitive edge.

The backlash has generated massive, viral free media attention. The controversy, dubbed "digital necromancy" by critics, spread rapidly across academic social media within hours of the initial post. This firestorm has brought the feature to the forefront of public and professional scrutiny, creating a significant awareness spike. While the legal and ethical questions are unresolved, the sheer volume of discussion acts as a powerful, if unintended, marketing amplifier for the product.

The immediate market attention is a double-edged sword. On one side, it validates the feature's visibility and the company's rebranding push. On the other, it introduces severe reputational risk and potential regulatory scrutiny. The scale of the backlash suggests the feature has already captured a substantial portion of the academic market's attention, for better or worse. The path forward will depend on how the company navigates this controversy while attempting to convert that attention into paying customers.

Price Impact and Trading Volume Patterns

The immediate financial impact on Grammarly's valuation is a function of reputational risk and legal uncertainty. The "digital necromancy" backlash has created a high-liquidity event in the form of intense public debate, which could influence user sentiment and churn rates. While no direct price action data is yet available, the scale of the controversy introduces severe reputational risk that could pressure the stock's multiple, especially if the legal and ethical questions lead to regulatory scrutiny or class-action claims.

The core legal risk involves copyright and right of publicity violations from training AI models on publicly available work without consent. Critics argue the feature exploits scholars' names, reputations, and published work to sell a product they never agreed to endorse. This creates a clear liability exposure, as the company's own description of the tool as drawing on "insights from subject-matter experts and trusted publications" may not cover the use of deceased individuals' identities without permission.

For now, the market's focus is on sentiment shifts rather than trading volume. The viral nature of the backlash, spreading rapidly across academic social media within hours, has brought the feature to the forefront of public scrutiny. This firestorm acts as a powerful, if unintended, marketing amplifier, but it simultaneously introduces a major red flag for investors. The path forward will depend on how the company navigates this controversy while attempting to convert the generated attention into paying customers.

Catalysts and Liquidity Events

The near-term catalysts are binary: a swift, damaging legal response or a strategic pivot that contains the fallout. The feature's launch has already triggered a firestorm, with critics calling it "digital necromancy" and accusing Grammarly of exploiting scholars' names and reputations without consent. The first major liquidity event will be any official response from the company in the coming weeks. A feature removal or significant policy change would signal a material reputational loss, likely pressuring the stock's multiple. Conversely, a defensive stance could escalate legal risks.

Formal legal actions are the most direct path to a costly liability. The core issue is copyright and right of publicity violations from training AI models on publicly available work. The feature's use of deceased academics, like historian David Abulafia who died in January, creates a clear vector for claims from estates. Watch for any cease-and-desist letters or class-action filings, which would introduce severe financial and operational uncertainty. The scale of the academic backlash suggests these claims are not just theoretical.

User sentiment and churn will be the ultimate profit indicator, visible in the next earnings report. The viral nature of the controversy has brought massive free attention, but its impact on subscription growth is the key metric. The company's own description of the tool as drawing on "insights from subject-matter experts" may not cover the use of deceased identities without permission. Monitor for any mention of user pushback or a shift in the growth trajectory for its premium AI services.